611 MYLAN (Methyldopa 250 mg)
Pill imprint 611 MYLAN has been identified as Methyldopa 250 mg.
Methyldopa is used in the treatment of high blood pressure; hypertensive emergency and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Methyldopa 250 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 250 mg
- 11.00 mm
- Prescription only
sodium lauryl sulfate
FD&C Yellow No. 6
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|51079-0200||UDL Laboratories Inc|
|54569-0508||A-S Medication Solutions, LLC (repackager)|
Note: Inactive ingredients may vary.
More about methyldopa
- Other brands: Aldomet
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.